Matches in DBpedia 2016-04 for { ?s ?p "Abacavir/lamivudine (INNs) is a combination drug for the treatment of HIV infection. It is marketed as Kivexa in most countries except for the United States, where it is branded as Epzicom. It is a fixed dose combination of a certain crystal form of lamivudine (3TC, Epivir) and the hemisulphate salt of abacavir (ABC, Ziagen). Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI).It was approved by the FDA on August 2, 2004. It is marketed by ViiV Healthcare."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- lamivudine abstract "Abacavir/lamivudine (INNs) is a combination drug for the treatment of HIV infection. It is marketed as Kivexa in most countries except for the United States, where it is branded as Epzicom. It is a fixed dose combination of a certain crystal form of lamivudine (3TC, Epivir) and the hemisulphate salt of abacavir (ABC, Ziagen). Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI).It was approved by the FDA on August 2, 2004. It is marketed by ViiV Healthcare.".
- Q4663143 abstract "Abacavir/lamivudine (INNs) is a combination drug for the treatment of HIV infection. It is marketed as Kivexa in most countries except for the United States, where it is branded as Epzicom. It is a fixed dose combination of a certain crystal form of lamivudine (3TC, Epivir) and the hemisulphate salt of abacavir (ABC, Ziagen). Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI).It was approved by the FDA on August 2, 2004. It is marketed by ViiV Healthcare.".
- lamivudine comment "Abacavir/lamivudine (INNs) is a combination drug for the treatment of HIV infection. It is marketed as Kivexa in most countries except for the United States, where it is branded as Epzicom. It is a fixed dose combination of a certain crystal form of lamivudine (3TC, Epivir) and the hemisulphate salt of abacavir (ABC, Ziagen). Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI).It was approved by the FDA on August 2, 2004. It is marketed by ViiV Healthcare.".
- Q4663143 comment "Abacavir/lamivudine (INNs) is a combination drug for the treatment of HIV infection. It is marketed as Kivexa in most countries except for the United States, where it is branded as Epzicom. It is a fixed dose combination of a certain crystal form of lamivudine (3TC, Epivir) and the hemisulphate salt of abacavir (ABC, Ziagen). Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI).It was approved by the FDA on August 2, 2004. It is marketed by ViiV Healthcare.".